Skip to main content
. 2021 Aug 29;144(15):1196–1211. doi: 10.1161/CIRCULATIONAHA.121.056680

Figure 1.

Figure 1.

Schematic trial design. ASA indicates acetylsalicyclic acid; DAPT, dual antiplatelet therapy; M, month; OAC, oral anticoagulation; PCI, percutaneous coronary intervention; and SAPT, single antiplatelet therapy.